Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01134120 · ClinicalTrials.gov registry record · Phase 1
A Study in Myeloproliferative Disorders
A Phase 1 study, sponsored by Eli Lilly and Company.
- Completed
- Registry status
- Phase 1
- Development phase
- 80
- Enrollment target
NCT01134120 is a Phase 1 study that has completed, run by Eli Lilly and Company. The registered enrollment target is 80 participants.
The verdict
NCT01134120, a Phase 1 study, has completed, sponsored by Eli Lilly and Company.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 80 participants
- Enrollment target
Study Summary
The purpose of this study is to find out the safe dose range of the study drug in patients with myeloproliferative disorders.
Interventions
- DRUG LY2784544
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2010-04 |
| Est. Completion | 2018-02-22 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01134120
The ClinicalTrials.gov registry entry for NCT01134120 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eli Lilly and Company, which has 1,341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which LY2784544 is the first listed.
NCT01134120 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01134120 about?
NCT01134120 is a clinical study titled "A Study in Myeloproliferative Disorders". The purpose of this study is to find out the safe dose range of the study drug in patients with myeloproliferative disorders.
What is the current status of trial NCT01134120?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 80 participants. The study started on 2010-04. Estimated completion is 2018-02-22.
What interventions are being tested in trial NCT01134120?
The interventions under investigation include: LY2784544 (DRUG).
Who is sponsoring clinical trial NCT01134120?
This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.